Accessibility Menu
 

The Best of 2012 #8: TearLab

A leader in tear testing for biomarker analysis, TearLab is up 296% this year, making it #8 on our list of the best stocks in healthcare for 2012.

By Dave Williamson and Max Macaluso Dec 13, 2012 at 5:19PM EST

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.